25 XP   0   0   10

Oxford BioMedica PLC
Buy, Hold or Sell?

Let's analyse Oxford BioMedica PLC together

PenkeI guess you are interested in Oxford BioMedica PLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oxford BioMedica PLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Oxford BioMedica PLC

I send you an email if I find something interesting about Oxford BioMedica PLC.

Quick analysis of Oxford BioMedica PLC (30 sec.)










What can you expect buying and holding a share of Oxford BioMedica PLC? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p236.29
Expected worth in 1 year
p431.79
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
p195.50
Return On Investment
95.4%

For what price can you sell your share?

Current Price per Share
p205.00
Expected price per share
p167.00 - p232.50
How sure are you?
50%

1. Valuation of Oxford BioMedica PLC (5 min.)




Live pricePrice per Share (EOD)

p205.00

Intrinsic Value Per Share

p-304.99 - p-60.33

Total Value Per Share

p-68.69 - p175.96

2. Growth of Oxford BioMedica PLC (5 min.)




Is Oxford BioMedica PLC growing?

Current yearPrevious yearGrowGrow %
How rich?$293.7m$232.9m$60.7m20.7%

How much money is Oxford BioMedica PLC making?

Current yearPrevious yearGrowGrow %
Making money-$56.1m$23.6m-$79.8m-142.1%
Net Profit Margin-32.3%13.3%--

How much money comes from the company's main activities?

3. Financial Health of Oxford BioMedica PLC (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Oxford BioMedica PLC? (5 min.)

Welcome investor! Oxford BioMedica PLC's management wants to use your money to grow the business. In return you get a share of Oxford BioMedica PLC.

What can you expect buying and holding a share of Oxford BioMedica PLC?

First you should know what it really means to hold a share of Oxford BioMedica PLC. And how you can make/lose money.

Speculation

The Price per Share of Oxford BioMedica PLC is p205.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oxford BioMedica PLC.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oxford BioMedica PLC, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p236.29. Based on the TTM, the Book Value Change Per Share is p48.87 per quarter. Based on the YOY, the Book Value Change Per Share is p74.62 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oxford BioMedica PLC.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-0.56-0.3%-0.56-0.3%0.240.1%-0.100.0%-0.12-0.1%
Usd Book Value Change Per Share0.610.3%0.610.3%0.930.5%0.570.3%0.270.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.610.3%0.610.3%0.930.5%0.570.3%0.270.1%
Usd Price Per Share5.50-5.50-15.30-10.08-5.08-
Price to Earnings Ratio-9.79--9.79-64.67--11.27--5.89-
Price-to-Total Gains Ratio9.05-9.05-16.48-18.75-9.44-
Price to Book Ratio1.87-1.87-6.56-9.29-4.93-
Price-to-Total Gains Ratio9.05-9.05-16.48-18.75-9.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.54938
Number of shares392
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.610.57
Usd Total Gains Per Share0.610.57
Gains per Quarter (392 shares)238.26224.39
Gains per Year (392 shares)953.04897.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
109539430898888
2019061896017951786
3028592849026932684
4038123802035903582
5047654755044884480
6057185708053855378
7066716661062836276
8076247614071807174
9085778567080788072
10095309520089758970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.08.00.020.0%2.024.00.07.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.03.00.070.0%16.010.00.061.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.026.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.03.00.070.0%16.010.00.061.5%

Fundamentals of Oxford BioMedica PLC

About Oxford BioMedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Fundamental data was last updated by Penke on 2024-04-02 21:44:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Oxford BioMedica PLC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oxford BioMedica PLC earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Oxford BioMedica PLC to the Biotechnology industry mean.
  • A Net Profit Margin of -32.3% means that -0.32 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oxford BioMedica PLC:

  • The MRQ is -32.3%. The company is making a huge loss. -2
  • The TTM is -32.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-32.3%TTM-32.3%0.0%
TTM-32.3%YOY13.3%-45.6%
TTM-32.3%5Y-8.0%-24.3%
5Y-8.0%10Y-47.6%+39.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.3%-197.2%+164.9%
TTM-32.3%-210.4%+178.1%
YOY13.3%-279.3%+292.6%
5Y-8.0%-436.8%+428.8%
10Y-47.6%-599.3%+551.7%
1.1.2. Return on Assets

Shows how efficient Oxford BioMedica PLC is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oxford BioMedica PLC to the Biotechnology industry mean.
  • -9.8% Return on Assets means that Oxford BioMedica PLC generated -0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oxford BioMedica PLC:

  • The MRQ is -9.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-9.8%0.0%
TTM-9.8%YOY8.0%-17.8%
TTM-9.8%5Y-2.3%-7.5%
5Y-2.3%10Y-18.7%+16.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-13.6%+3.8%
TTM-9.8%-12.9%+3.1%
YOY8.0%-11.9%+19.9%
5Y-2.3%-14.2%+11.9%
10Y-18.7%-16.2%-2.5%
1.1.3. Return on Equity

Shows how efficient Oxford BioMedica PLC is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oxford BioMedica PLC to the Biotechnology industry mean.
  • -22.1% Return on Equity means Oxford BioMedica PLC generated -0.22 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oxford BioMedica PLC:

  • The MRQ is -22.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.1%TTM-22.1%0.0%
TTM-22.1%YOY10.1%-32.2%
TTM-22.1%5Y-3.4%-18.7%
5Y-3.4%10Y-57.7%+54.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.1%-17.0%-5.1%
TTM-22.1%-16.1%-6.0%
YOY10.1%-15.4%+25.5%
5Y-3.4%-20.0%+16.6%
10Y-57.7%-21.1%-36.6%

1.2. Operating Efficiency of Oxford BioMedica PLC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oxford BioMedica PLC is operating .

  • Measures how much profit Oxford BioMedica PLC makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oxford BioMedica PLC to the Biotechnology industry mean.
  • An Operating Margin of -36.8% means the company generated -0.37  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oxford BioMedica PLC:

  • The MRQ is -36.8%. The company is operating very inefficient. -2
  • The TTM is -36.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-36.8%TTM-36.8%0.0%
TTM-36.8%YOY14.5%-51.4%
TTM-36.8%5Y-7.9%-28.9%
5Y-7.9%10Y-51.1%+43.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.8%-286.1%+249.3%
TTM-36.8%-224.4%+187.6%
YOY14.5%-288.4%+302.9%
5Y-7.9%-475.2%+467.3%
10Y-51.1%-624.7%+573.6%
1.2.2. Operating Ratio

Measures how efficient Oxford BioMedica PLC is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are 1.37 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Oxford BioMedica PLC:

  • The MRQ is 1.368. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.368. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.368TTM1.3680.000
TTM1.368YOY0.853+0.515
TTM1.3685Y1.071+0.297
5Y1.07110Y1.502-0.431
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3682.997-1.629
TTM1.3683.247-1.879
YOY0.8533.766-2.913
5Y1.0715.675-4.604
10Y1.5027.857-6.355

1.3. Liquidity of Oxford BioMedica PLC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oxford BioMedica PLC is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.61 means the company has 3.61 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Oxford BioMedica PLC:

  • The MRQ is 3.612. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.612. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.612TTM3.6120.000
TTM3.612YOY4.919-1.307
TTM3.6125Y2.999+0.613
5Y2.99910Y2.571+0.429
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6123.930-0.318
TTM3.6124.251-0.639
YOY4.9195.436-0.517
5Y2.9996.045-3.046
10Y2.5716.363-3.792
1.3.2. Quick Ratio

Measures if Oxford BioMedica PLC is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oxford BioMedica PLC to the Biotechnology industry mean.
  • A Quick Ratio of 3.33 means the company can pay off 3.33 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oxford BioMedica PLC:

  • The MRQ is 3.334. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.334. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.334TTM3.3340.000
TTM3.334YOY4.539-1.205
TTM3.3345Y2.757+0.577
5Y2.75710Y1.877+0.880
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3343.629-0.295
TTM3.3344.065-0.731
YOY4.5395.397-0.858
5Y2.7575.993-3.236
10Y1.8776.277-4.400

1.4. Solvency of Oxford BioMedica PLC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oxford BioMedica PLC assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oxford BioMedica PLC to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.49 means that Oxford BioMedica PLC assets are financed with 48.7% credit (debt) and the remaining percentage (100% - 48.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oxford BioMedica PLC:

  • The MRQ is 0.487. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.487. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.487TTM0.4870.000
TTM0.487YOY0.210+0.276
TTM0.4875Y0.432+0.055
5Y0.43210Y0.530-0.098
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4870.332+0.155
TTM0.4870.334+0.153
YOY0.2100.268-0.058
5Y0.4320.366+0.066
10Y0.5300.390+0.140
1.4.2. Debt to Equity Ratio

Measures if Oxford BioMedica PLC is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oxford BioMedica PLC to the Biotechnology industry mean.
  • A Debt to Equity ratio of 109.4% means that company has 1.09 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oxford BioMedica PLC:

  • The MRQ is 1.094. The company is able to pay all its debts with equity. +1
  • The TTM is 1.094. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.094TTM1.0940.000
TTM1.094YOY0.266+0.828
TTM1.0945Y0.971+0.124
5Y0.97110Y2.277-1.306
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0940.381+0.713
TTM1.0940.390+0.704
YOY0.2660.334-0.068
5Y0.9710.434+0.537
10Y2.2770.466+1.811

2. Market Valuation of Oxford BioMedica PLC

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Oxford BioMedica PLC generates.

  • Above 15 is considered overpriced but always compare Oxford BioMedica PLC to the Biotechnology industry mean.
  • A PE ratio of -9.79 means the investor is paying -9.79 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oxford BioMedica PLC:

  • The EOD is -4.538. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.795. Based on the earnings, the company is expensive. -2
  • The TTM is -9.795. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.538MRQ-9.795+5.257
MRQ-9.795TTM-9.7950.000
TTM-9.795YOY64.672-74.466
TTM-9.7955Y-11.275+1.480
5Y-11.27510Y-5.891-5.383
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.538-2.315-2.223
MRQ-9.795-2.560-7.235
TTM-9.795-2.664-7.131
YOY64.672-4.122+68.794
5Y-11.275-6.258-5.017
10Y-5.891-6.108+0.217
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oxford BioMedica PLC:

  • The EOD is -7.088. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.299. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.299. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.088MRQ-15.299+8.211
MRQ-15.299TTM-15.2990.000
TTM-15.299YOY76.871-92.170
TTM-15.2995Y39.784-55.083
5Y39.78410Y20.646+19.138
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.088-3.067-4.021
MRQ-15.299-3.251-12.048
TTM-15.299-3.545-11.754
YOY76.871-5.595+82.466
5Y39.784-8.315+48.099
10Y20.646-8.708+29.354
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oxford BioMedica PLC is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.87 means the investor is paying 1.87 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Oxford BioMedica PLC:

  • The EOD is 0.868. Based on the equity, the company is cheap. +2
  • The MRQ is 1.873. Based on the equity, the company is underpriced. +1
  • The TTM is 1.873. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.868MRQ1.873-1.005
MRQ1.873TTM1.8730.000
TTM1.873YOY6.563-4.690
TTM1.8735Y9.288-7.415
5Y9.28810Y4.929+4.359
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8681.905-1.037
MRQ1.8732.111-0.238
TTM1.8732.095-0.222
YOY6.5632.836+3.727
5Y9.2883.443+5.845
10Y4.9293.794+1.135
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Oxford BioMedica PLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--48.87548.8750%74.624-35%46.029+6%21.664+126%
Book Value Per Share--236.293236.2930%187.418+26%129.385+83%70.854+233%
Current Ratio--3.6123.6120%4.919-27%2.999+20%2.571+41%
Debt To Asset Ratio--0.4870.4870%0.210+131%0.432+13%0.530-8%
Debt To Equity Ratio--1.0941.0940%0.266+311%0.971+13%2.277-52%
Dividend Per Share----0%-0%-0%-0%
Eps---45.178-45.1780%19.019-338%-8.187-82%-9.939-78%
Free Cash Flow Per Share---28.923-28.9230%16.001-281%-9.948-66%-11.372-61%
Free Cash Flow To Equity Per Share--69.74169.7410%62.228+12%31.081+124%17.903+290%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---60.331--------
Intrinsic Value_10Y_min---304.985--------
Intrinsic Value_1Y_max---7.378--------
Intrinsic Value_1Y_min---16.376--------
Intrinsic Value_3Y_max---21.152--------
Intrinsic Value_3Y_min---61.782--------
Intrinsic Value_5Y_max---33.703--------
Intrinsic Value_5Y_min---120.625--------
Market Cap20491267000.000-116%44231149500.00044231149500.0000%122947602000.000-64%81059453956.000-45%40799561979.300+8%
Net Profit Margin---0.323-0.3230%0.133-342%-0.080-75%-0.476+47%
Operating Margin---0.368-0.3680%0.145-353%-0.079-79%-0.511+39%
Operating Ratio--1.3681.3680%0.853+60%1.071+28%1.502-9%
Pb Ratio0.868-116%1.8731.8730%6.563-71%9.288-80%4.929-62%
Pe Ratio-4.538+54%-9.795-9.7950%64.672-115%-11.275+15%-5.891-40%
Price Per Share205.000-116%442.500442.5000%1230.000-64%810.940-45%408.170+8%
Price To Free Cash Flow Ratio-7.088+54%-15.299-15.2990%76.871-120%39.784-138%20.646-174%
Price To Total Gains Ratio4.194-116%9.0549.0540%16.483-45%18.753-52%9.438-4%
Quick Ratio--3.3343.3340%4.539-27%2.757+21%1.877+78%
Return On Assets---0.098-0.0980%0.080-222%-0.023-76%-0.187+90%
Return On Equity---0.221-0.2210%0.101-317%-0.034-85%-0.577+162%
Total Gains Per Share--48.87548.8750%74.624-35%46.029+6%21.664+126%
Usd Book Value--293728371.200293728371.2000%232973536.800+26%160834041.840+83%88076602.040+233%
Usd Book Value Change Per Share--0.6080.6080%0.928-35%0.572+6%0.269+126%
Usd Book Value Per Share--2.9392.9390%2.331+26%1.609+83%0.881+233%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.562-0.5620%0.237-338%-0.102-82%-0.124-78%
Usd Free Cash Flow---35953719.600-35953719.6000%19890138.400-281%-12366607.120-66%-14136498.640-61%
Usd Free Cash Flow Per Share---0.360-0.3600%0.199-281%-0.124-66%-0.141-61%
Usd Free Cash Flow To Equity Per Share--0.8670.8670%0.774+12%0.387+124%0.223+290%
Usd Market Cap254829396.412-116%550058575.182550058575.1820%1528976378.472-64%1008055369.397-45%507383352.775+8%
Usd Price Per Share2.549-116%5.5035.5030%15.296-64%10.085-45%5.076+8%
Usd Profit---56159732.400-56159732.4000%23642079.600-338%-10177124.960-82%-12355414.720-78%
Usd Revenue--174090320.400174090320.4000%177582349.200-2%124696269.440+40%74817463.200+133%
Usd Total Gains Per Share--0.6080.6080%0.928-35%0.572+6%0.269+126%
 EOD+2 -6MRQTTM+0 -0YOY+9 -245Y+15 -1810Y+25 -8

3.2. Fundamental Score

Let's check the fundamental score of Oxford BioMedica PLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.538
Price to Book Ratio (EOD)Between0-10.868
Net Profit Margin (MRQ)Greater than0-0.323
Operating Margin (MRQ)Greater than0-0.368
Quick Ratio (MRQ)Greater than13.334
Current Ratio (MRQ)Greater than13.612
Debt to Asset Ratio (MRQ)Less than10.487
Debt to Equity Ratio (MRQ)Less than11.094
Return on Equity (MRQ)Greater than0.15-0.221
Return on Assets (MRQ)Greater than0.05-0.098
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Oxford BioMedica PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.673
Ma 20Greater thanMa 50199.120
Ma 50Greater thanMa 100188.808
Ma 100Greater thanMa 200189.212
OpenGreater thanClose196.000
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Total Other Income Expense Net -24,500-806,000-830,500656,200-174,30085,500-88,800647,000558,200



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets460,180
Total Liabilities223,988
Total Stockholder Equity204,653
 As reported
Total Liabilities 223,988
Total Stockholder Equity+ 204,653
Total Assets = 460,180

Assets

Total Assets460,180
Total Current Assets215,504
Long-term Assets244,676
Total Current Assets
Cash And Cash Equivalents 141,285
Short-term Investments 23
Net Receivables 57,595
Inventory 12,625
Other Current Assets 3,976
Total Current Assets  (as reported)215,504
Total Current Assets  (calculated)215,504
+/-0
Long-term Assets
Property Plant Equipment 133,780
Goodwill 661
Intangible Assets 105,225
Long-term Assets  (as reported)244,676
Long-term Assets  (calculated)239,666
+/- 5,010

Liabilities & Shareholders' Equity

Total Current Liabilities59,663
Long-term Liabilities164,325
Total Stockholder Equity204,653
Total Current Liabilities
Short-term Debt 3,295
Accounts payable 13,604
Other Current Liabilities 23,500
Total Current Liabilities  (as reported)59,663
Total Current Liabilities  (calculated)40,399
+/- 19,264
Long-term Liabilities
Long term Debt 39,780
Capital Lease Obligations 74,501
Long-term Liabilities  (as reported)164,325
Long-term Liabilities  (calculated)114,281
+/- 50,044
Total Stockholder Equity
Common Stock48,132
Retained Earnings -198,545
Other Stockholders Equity 355,066
Total Stockholder Equity (as reported)204,653
Total Stockholder Equity (calculated)204,653
+/-0
Other
Capital Stock48,132
Cash and Short Term Investments 141,308
Common Stock Shares Outstanding 94,830
Current Deferred Revenue19,264
Liabilities and Stockholders Equity 460,180
Net Debt -27,004
Net Invested Capital 244,433
Net Working Capital 155,841
Property Plant and Equipment Gross 188,238
Short Long Term Debt Total 114,281



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-09-30
> Total Assets 
1,251
3,202
5,241
4,602
14,317
39,264
26,792
36,714
28,584
49,241
35,538
61,162
43,122
43,949
25,645
26,095
24,423
13,644
33,805
51,851
56,942
65,402
112,400
122,928
183,928
237,229
460,180
460,180237,229183,928122,928112,40065,40256,94251,85133,80513,64424,42326,09525,64543,94943,12261,16235,53849,24128,58436,71426,79239,26414,3174,6025,2413,2021,251
   > Total Current Assets 
748
1,737
3,924
3,471
12,704
35,357
23,187
34,222
25,720
46,769
33,054
45,442
31,315
32,199
18,382
18,776
17,590
6,941
22,755
25,712
27,441
36,981
69,526
56,937
107,946
163,844
215,504
215,504163,844107,94656,93769,52636,98127,44125,71222,7556,94117,59018,77618,38232,19931,31545,44233,05446,76925,72034,22223,18735,35712,7043,4713,9241,737748
       Cash And Cash Equivalents 
708
1,512
3,566
3,039
11,635
32,645
20,964
31,836
40
20,317
8,043
10,962
8,141
6,802
6,653
6,835
8,956
2,169
14,195
9,355
15,335
14,329
32,244
16,243
46,743
108,944
141,285
141,285108,94446,74316,24332,24414,32915,3359,35514,1952,1698,9566,8356,6536,8028,14110,9628,04320,3174031,83620,96432,64511,6353,0393,5661,512708
       Short-term Investments 
0
0
0
0
0
0
0
31,700
22,377
23,500
20,500
27,185
13,750
18,500
5,603
7,500
5,105
0
0
0
0
0
0
2,719
239
74
23
23742392,7190000005,1057,5005,60318,50013,75027,18520,50023,50022,37731,7000000000
       Net Receivables 
0
0
0
0
804
2,284
1,791
1,944
2,804
2,305
3,758
4,291
6,952
4,730
3,308
2,942
2,863
3,490
6,374
12,803
9,456
17,929
28,191
33,623
51,423
42,095
57,595
57,59542,09551,42333,62328,19117,9299,45612,8036,3743,4902,8632,9423,3084,7306,9524,2913,7582,3052,8041,9441,7912,2848040000
       Other Current Assets 
0
0
0
0
265
428
432
442
499
647
753
3,004
2,472
2,167
2,818
1,499
666
602
779
848
0
19,320
33,031
1,773
2,629
3,210
3,976
3,9763,2102,6291,77333,03119,32008487796026661,4992,8182,1672,4723,0047536474994424324282650000
   > Long-term Assets 
503
1,465
1,317
1,131
1,613
3,907
3,605
2,492
2,864
2,472
2,484
15,720
11,807
11,750
7,263
7,319
6,833
6,703
11,050
26,139
29,501
28,421
42,874
65,991
75,982
73,385
244,676
244,67673,38575,98265,99142,87428,42129,50126,13911,0506,7036,8337,3197,26311,75011,80715,7202,4842,4722,8642,4923,6053,9071,6131,1311,3171,465503
       Property Plant Equipment 
11
1,034
936
773
1,304
3,647
3,394
2,331
1,237
831
819
810
688
631
580
4,213
3,902
4,070
8,944
24,396
27,514
25,370
31,791
61,932
72,304
69,728
133,780
133,78069,72872,30461,93231,79125,37027,51424,3968,9444,0703,9024,2135806316888108198311,2372,3313,3943,6471,3047739361,03411
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
661
66100000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
657
2,954
10,966
0
0
0
0
000010,9662,95465700000000000000000000
       Intangible Assets 
492
431
381
332
283
234
185
135
1,627
1,641
1,665
14,910
11,119
11,119
6,683
3,106
2,931
2,633
2,106
1,743
1,330
97
117
95
73
52
105,225
105,225527395117971,3301,7432,1062,6332,9313,1066,68311,11911,11914,9101,6651,6411,627135185234283332381431492
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
10,400
6,802
0
0
0
0
0
0
0
0
0
4,000
3,964
3,605
3,605
0
03,6053,6053,9644,0000000000006,80210,40000000000000
> Total Liabilities 
126
441
480
801
1,340
1,756
1,260
1,501
2,205
2,641
5,448
29,230
19,851
22,973
14,040
8,324
4,780
4,746
10,766
40,957
44,327
59,256
77,659
47,298
71,182
49,891
223,988
223,98849,89171,18247,29877,65959,25644,32740,95710,7664,7464,7808,32414,04022,97319,85129,2305,4482,6412,2051,5011,2601,7561,340801480441126
   > Total Current Liabilities 
126
441
480
801
1,340
1,756
1,254
1,501
1,814
2,248
4,821
21,161
15,132
13,308
9,218
7,653
4,270
4,214
9,231
13,169
9,316
21,762
28,506
28,941
52,455
33,307
59,663
59,66333,30752,45528,94128,50621,7629,31613,1699,2314,2144,2707,6539,21813,30815,13221,1614,8212,2481,8141,5011,2541,7561,340801480441126
       Short-term Debt 
0
0
0
0
0
0
0
31,700
22,377
23,500
20,500
27,185
13,750
18,500
5,603
7,500
5,105
0
1,000
27,255
34,389
36,864
0
482
4,475
853
3,295
3,2958534,475482036,86434,38927,2551,00005,1057,5005,60318,50013,75027,18520,50023,50022,37731,7000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
27,255
34,389
36,864
0
0
0
0
0
0000036,86434,38927,2551,000000000000000000000
       Accounts payable 
0
0
0
0
430
638
379
310
351
397
1,579
2,948
3,298
1,965
1,277
1,200
881
1,218
2,787
3,588
1,576
3,682
3,746
7,311
7,777
5,260
13,604
13,6045,2607,7777,3113,7463,6821,5763,5882,7871,2188811,2001,2771,9653,2982,9481,5793973513103796384300000
       Other Current Liabilities 
0
0
0
0
910
1,118
875
1,191
1,390
1,851
3,242
18,213
11,834
11,343
7,941
6,453
3,389
2,996
6,444
4,267
3,755
18,080
24,760
6,986
11,939
13,798
23,500
23,50013,79811,9396,98624,76018,0803,7554,2676,4442,9963,3896,4537,94111,34311,83418,2133,2421,8511,3901,1918751,1189100000
   > Long-term Liabilities 
0
0
0
0
0
0
6
0
391
393
627
8,069
4,719
9,665
4,822
671
510
532
1,535
27,788
35,011
37,494
49,153
18,357
18,727
16,584
164,325
164,32516,58418,72718,35749,15337,49435,01127,7881,5355325106714,8229,6654,7198,06962739339106000000
       Other Liabilities 
0
0
0
0
0
0
0
0
464
393
627
8,069
4,719
9,665
4,822
671
510
532
535
533
622
630
8,000
10,450
9,357
8,096
0
08,0969,35710,4508,0006306225335355325106714,8229,6654,7198,06962739346400000000
> Total Stockholder Equity
0
0
0
0
12,977
37,508
25,532
35,213
24,838
46,600
30,090
31,932
23,271
20,976
11,605
17,771
19,643
8,898
23,039
10,894
12,615
6,146
34,741
75,630
112,746
187,338
204,653
204,653187,338112,74675,63034,7416,14612,61510,89423,0398,89819,64317,77111,60520,97623,27131,93230,09046,60024,83835,21325,53237,50812,9770000
   Common Stock
0
0
0
0
1,721
2,382
2,388
3,703
3,721
4,984
5,014
5,347
5,373
5,412
5,449
9,449
14,162
14,162
25,659
25,741
30,879
31,076
33,034
38,416
41,161
43,088
48,132
48,13243,08841,16138,41633,03431,07630,87925,74125,65914,16214,1629,4495,4495,4125,3735,3475,0144,9843,7213,7032,3882,3821,7210000
   Retained Earnings Total Equity000000000000000000000000000
   Accumulated Other Comprehensive Income -27,1780-29,970-20,184-14,652-10,320-8,497-8,631-7,367-6,664-5,993-5,835-5,740-5,487-5,324-5,038-4,827-4,445-3,864-3,334-2,575-1,818-1,024-722-428-165-1
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
172,074
222,618
258,017
0
0
00258,017222,618172,0740000000000000000000000
   Treasury Stock000000-102-102-226000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,628
1,609
2,291
2,291
168,053
190,235
224,909
260,308
310,056
355,066
355,066310,056260,308224,909190,235168,0532,2912,2911,60913,62800000000000000000



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue139,989
Cost of Revenue-70,808
Gross Profit69,18169,181
 
Operating Income (+$)
Gross Profit69,181
Operating Expense-120,739
Operating Income-51,558-51,558
 
Operating Expense (+$)
Research Development60,937
Selling General Administrative28,223
Selling And Marketing Expenses0
Operating Expense120,73989,160
 
Net Interest Income (+$)
Interest Income973
Interest Expense-16,729
Other Finance Cost-0
Net Interest Income-15,756
 
Pretax Income (+$)
Operating Income-51,558
Net Interest Income-15,756
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-45,976-57,140
EBIT - interestExpense = -68,287
-45,976
-28,430
Interest Expense16,729
Earnings Before Interest and Taxes (EBIT)-51,558-29,247
Earnings Before Interest and Taxes (EBITDA)-24,226
 
After tax Income (+$)
Income Before Tax-45,976
Tax Provision--817
Net Income From Continuing Ops-45,159-45,159
Net Income-45,159
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses191,547
Total Other Income/Expenses Net5,58215,756
 

Technical Analysis of Oxford BioMedica PLC
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oxford BioMedica PLC. The general trend of Oxford BioMedica PLC is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oxford BioMedica PLC's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oxford BioMedica PLC.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 220.00 < 220.50 < 232.50.

The bearish price targets are: 187.00 > 183.60 > 167.00.

Tweet this
Oxford BioMedica PLC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oxford BioMedica PLC. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oxford BioMedica PLC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oxford BioMedica PLC. The current macd is 2.56840725.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oxford BioMedica PLC price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Oxford BioMedica PLC. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Oxford BioMedica PLC price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Oxford BioMedica PLC Daily Moving Average Convergence/Divergence (MACD) ChartOxford BioMedica PLC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oxford BioMedica PLC. The current adx is 26.25.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Oxford BioMedica PLC shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Oxford BioMedica PLC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oxford BioMedica PLC. The current sar is 187.83.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Oxford BioMedica PLC Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oxford BioMedica PLC. The current rsi is 56.67. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Oxford BioMedica PLC Daily Relative Strength Index (RSI) ChartOxford BioMedica PLC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oxford BioMedica PLC. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Oxford BioMedica PLC price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Oxford BioMedica PLC Daily Stochastic Oscillator ChartOxford BioMedica PLC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oxford BioMedica PLC. The current cci is 42.44.

Oxford BioMedica PLC Daily Commodity Channel Index (CCI) ChartOxford BioMedica PLC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oxford BioMedica PLC. The current cmo is 14.51.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Oxford BioMedica PLC Daily Chande Momentum Oscillator (CMO) ChartOxford BioMedica PLC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oxford BioMedica PLC. The current willr is -21.39310086.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Oxford BioMedica PLC is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Oxford BioMedica PLC Daily Williams %R ChartOxford BioMedica PLC Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Oxford BioMedica PLC.

Oxford BioMedica PLC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oxford BioMedica PLC. The current atr is 10.26.

Oxford BioMedica PLC Daily Average True Range (ATR) ChartOxford BioMedica PLC Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oxford BioMedica PLC. The current obv is -10,745,529.

Oxford BioMedica PLC Daily On-Balance Volume (OBV) ChartOxford BioMedica PLC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oxford BioMedica PLC. The current mfi is 51.21.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Oxford BioMedica PLC Daily Money Flow Index (MFI) ChartOxford BioMedica PLC Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oxford BioMedica PLC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Oxford BioMedica PLC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oxford BioMedica PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.673
Ma 20Greater thanMa 50199.120
Ma 50Greater thanMa 100188.808
Ma 100Greater thanMa 200189.212
OpenGreater thanClose196.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Oxford BioMedica PLC with someone you think should read this too:
  • Are you bullish or bearish on Oxford BioMedica PLC? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oxford BioMedica PLC? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oxford BioMedica PLC

I send you an email if I find something interesting about Oxford BioMedica PLC.


Comments

How you think about this?

Leave a comment

Stay informed about Oxford BioMedica PLC.

Receive notifications about Oxford BioMedica PLC in your mailbox!